Inventor · disambiguated record
John J. Engelhardt
Also filed as: ENGELHARDT JOHN J
6 granted patents·7 pending applications·56 citations·filing 2013–2025
83Inventor score
Files withBRISTOL MYERS SQUIBB CO13
Top patents by PatentIndex Score
13 records- 0197US10251945B2Anti-ICOS agonist antibodies and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Apr 9, 2019·20 cites·28 claims
- 0297US10196445B1Ipilimumab variant with enhanced ADCCBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Feb 5, 2019·22 cites·11 claims
- 0394US10898556B2Anti-ICOS agonist antibodies and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jan 26, 2021·7 cites·22 claims
- 0493US11207391B2Anti-ICOS agonist antibodies and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Dec 28, 2021·4 cites·20 claims
- 0591US10493140B2Anti-ICOS agonist antibodies and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Dec 3, 2019·3 cites·21 claims
- 0683US2023287064A1Enhancing anti-cancer activity of immunomodulatory fc fusion proteinsBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 0781US2024041995A1Anti-icos agonist antibodies and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 0874US11529399B2Anti-ICOS agonist antibodies and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Dec 20, 2022·0 cites·32 claims
- 0974US2025236650A1Enhancing anti-cancer activity of immunomodulatory fc fusion proteinsBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 1070US2020207816A1Enhancing anti-cancer activity of immunomodulatory fc fusion proteinsBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 1169US2018312553A1Enhancing anti-cancer activity of immunomodulatory fc fusion proteinsBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
- 1261US2015322119A1Enhancing anti-cancer activity of immunomodulatory fc fusion proteinsBRISTOL MYERS SQUIBB CO·Filed 2013·Application pending·0 cites
- 1357US2024002513A1Dosing and administration of non-fucosylated anti-ctla-4 antibody as monotherapyBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →